Senior insider sale
Co-Chief Executive Officer at AMYLYX PHARMACEUTICALS, INC. — senior position signals high conviction
$980.5K
30.46K shares
What this filing means
COHEN JOSHUA B plans to sell 30.46K shares of AMYLYX PHARMACEUTICALS, INC. valued at approximately $980.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/11/2026ACC: 0001193125-26-389243
DirectorOfficer· Co-Chief Executive Officer
Since Jan 2022
30.46K
Shares to sell
$980.5K
Approx. market value
60.04K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Vesting of Performance-based Restricted Stock Units
N/A
9/10/2026
60.04KTotal acquired60.04K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/10/2026 | Vesting of Performance-based Restricted Stock Units N/A | 60.04K | — |
| Total | 60.04K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
30.46K
Market value
$980.5K
9/10/2026
Total
Units
30.46K
Value
$980.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2026 | 30.46K | $980.5K | NASDAQ | Planned |
| Total | 30.46K | $980.5K | ||